Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model

BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) is a common skin cancer, affecting more than 2 million people worldwide yearly and metastasising in 2–5% of patients. However, current clinical staging systems do not provide estimates of absolute metastatic risk, hence missing the opportunity for...

Descripción completa

Detalles Bibliográficos
Autores principales: Rentroia-Pacheco, Barbara, Tokez, Selin, Bramer, Edo M., Venables, Zoe C., van de Werken, Harmen J.G., Bellomo, Domenico, van Klaveren, David, Mooyaart, Antien L., Hollestein, Loes M., Wakkee, Marlies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468358/
https://www.ncbi.nlm.nih.gov/pubmed/37662519
http://dx.doi.org/10.1016/j.eclinm.2023.102150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468358/
https://www.ncbi.nlm.nih.gov/pubmed/37662519
http://dx.doi.org/10.1016/j.eclinm.2023.102150

Ejemplares similares